Concepedia
Statistics
Publications
3
Citations
368
H-Index
Active since
2009
Affiliations
Mayo Clinic(Current)
Rutgers, The State University of New Jersey
Michelle Roos is an author at Mayo Clinic specializing in pharmacology, clinical pharmacology, and pharmacotherapy.
Publications per year
2009–2020
Phase I Trial of Daily Oral Polyphenon E in Patients With Asymptomatic Rai Stage 0 to II Chronic Lymphocytic Leukemia
Tait D. Shanafelt, Tim G. Call, Clive S. Zent et al. · Journal of Clinical Oncology · 2009 · 184 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +7
Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia
Tait D. Shanafelt, Timothy G. Call, Clive S. Zent et al. · Cancer · 2012 · 169 citations
Pharmacy, Pharmacology, Pharmacotherapy +8
A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors
Mojun Zhu, Julian R. Molina, Grace K. Dy et al. · Investigational New Drugs · 2020 · 15 citations
Medicine, Oncology, Pharmacology +16
1–3 of 3